Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


13.11.2017

1 Biomed Pharmacother
1 Bioorg Chem
1 BMC Cancer
1 Br J Cancer
1 Brachytherapy
1 Cancer Biomark
1 Cancer Causes Control
2 Cancer Epidemiol
1 Cancer Genomics Proteomics
1 Cancer Med
1 Cancer Res
1 Clin Microbiol Infect
1 Contemp Clin Trials
1 Exp Ther Med
2 Gynecol Oncol
1 Health Care Women Int
1 Int J Public Health
2 Int J Radiat Oncol Biol Phys
1 Intern Med
1 Isr Med Assoc J
1 J Cytol
1 J Family Reprod Health
2 Lancet HIV
1 Magn Reson Imaging
1 Mol Med Rep
2 Obstet Gynecol
1 Oncol Lett
2 Oncotarget
1 Pathol Res Pract
1 Rheum Dis Clin North Am
1 Surg Oncol
1 Ultrasound Obstet Gynecol
1 Womens Health Issues


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biomed Pharmacother

  1. FAROOQUI A, Khan F, Khan I, Ansari IA, et al
    Glycyrrhizin induces reactive oxygen species-dependent apoptosis and cell cycle arrest at G0/G1 in HPV18+ human cervical cancer HeLa cell line.
    Biomed Pharmacother. 2017;97:752-764.
    PubMed     Text format     Abstract available


    Bioorg Chem

  2. YU JS, Lee D, Lee SR, Lee JW, et al
    Chemical characterization of cytotoxic indole acetic acid derivative from mulberry fruit (Morus alba L.) against human cervical cancer.
    Bioorg Chem. 2017;76:28-36.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. LI S, Wen X
    Seropositivity to herpes simplex virus type 2, but not type 1 is associated with cervical cancer: NHANES (1999-2014).
    BMC Cancer. 2017;17:726.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. MARKOVINA S, Wang S, Henke LE, Luke CJ, et al
    Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
    Br J Cancer. 2017 Nov 7. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Brachytherapy

  5. SIMHA V, Rai B, Patel FD, Kapoor R, et al
    Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
    Brachytherapy. 2017 Nov 1. pii: S1538-4721(17)30466.
    PubMed     Text format     Abstract available


    Cancer Biomark

  6. WU DM, Shi J, Liu T, Deng SH, et al
    Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
    Cancer Biomark. 2017 Oct 19. doi: 10.3233/CBM-170501.
    PubMed     Text format     Abstract available


    Cancer Causes Control

  7. SILVER MI, Rositch AF, Phelan-Emrick DF, Gravitt PE, et al
    Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.
    Cancer Causes Control. 2017 Nov 9. doi: 10.1007/s10552-017-0976.
    PubMed     Text format     Abstract available


    Cancer Epidemiol

  8. SY AU, Hernandez BY, Tareg A, Reichhardt M, et al
    Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.
    Cancer Epidemiol. 2017;50.
    PubMed     Text format     Abstract available

  9. SENKOMAGO V, Royalty J, Miller JW, Buenconsejo-Lum LE, et al
    Cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in four US-Affiliated Pacific Islands between 2007 and 2015.
    Cancer Epidemiol. 2017;50.
    PubMed     Text format     Abstract available


    Cancer Genomics Proteomics

  10. PAPPA KI, Kontostathi G, Makridakis M, Lygirou V, et al
    High Resolution Proteomic Analysis of the Cervical Cancer Cell Lines Secretome Documents Deregulation of Multiple Proteases.
    Cancer Genomics Proteomics. 2017;14:507-521.
    PubMed     Text format     Abstract available


    Cancer Med

  11. LI X, Huang H, Guan Y, Gong Y, et al
    Whole-exome sequencing predicted cancer epitope trees of 23 early cervical cancers in Chinese women.
    Cancer Med. 2017;6:207-219.
    PubMed     Text format     Abstract available


    Cancer Res

  12. PAYEN VL, Hsu MY, Radecke KS, Wyart E, et al
    Monocarboxylate Transporter MCT1 Promotes Tumor Metastasis Independently of Its Activity as a Lactate Transporter.
    Cancer Res. 2017;77:5591-5601.
    PubMed     Text format     Abstract available


    Clin Microbiol Infect

  13. HAWKES D, Brotherton JML, Saville M
    Concordant testing results between various Human Papillomavirus assays in primary cervical cancer screening.
    Clin Microbiol Infect. 2017 Nov 2. pii: S1198-743X(17)30596.
    PubMed     Text format    


    Contemp Clin Trials

  14. WINER RL, Tiro JA, Miglioretti DL, Thayer C, et al
    Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
    Contemp Clin Trials. 2017 Nov 4. pii: S1551-7144(17)30453.
    PubMed     Text format     Abstract available


    Exp Ther Med

  15. TAO J, Dai J, Hou S
    Association between B7-H1 and cervical cancer: B7-H1 impairs the immune response in human cervical cancer cells.
    Exp Ther Med. 2017;14:4125-4133.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  16. LEE JH, Lee SW, Kim JR, Kim YS, et al
    Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.
    Gynecol Oncol. 2017 Oct 27. pii: S0090-8258(17)31360.
    PubMed     Text format     Abstract available

  17. SPAANS VM, Nyoman Bayu Mahendra I, Purwoto G, Trietsch MD, et al
    The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway.
    Gynecol Oncol. 2017 Nov 4. pii: S0090-8258(17)31369.
    PubMed     Text format     Abstract available


    Health Care Women Int

  18. NGUYEN AD, Hoang MV, Nguyen CC
    Medical costs for the treatment of cervical cancer at central hospitals in Vietnam.
    Health Care Women Int. 2017 Nov 10:0. doi: 10.1080/07399332.2017.1402912.
    PubMed     Text format     Abstract available


    Int J Public Health

  19. WYMANN MN, Zographos AS, Altpeter E, Spicher VM, et al
    Human papillomavirus vaccine uptake in adolescence and adherence to cervical cancer screening in Switzerland: a national cross-sectional survey.
    Int J Public Health. 2017 Nov 6. doi: 10.1007/s00038-017-1050.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  20. LIM-REINDERS S, Keller BM, Al-Ward S, Sahgal A, et al
    Online Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:994-1003.
    PubMed     Text format     Abstract available

  21. KOK HP, Korshuize-van Straten L, Bakker A, de Kroon-Oldenhof R, et al
    Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots.
    Int J Radiat Oncol Biol Phys. 2017;99:1039-1047.
    PubMed     Text format     Abstract available


    Intern Med

  22. YAMASAKI T, Yanishi K, Tateishi S, Nakanishi N, et al
    Late-onset Mitochondrial Cardiomyopathy Triggered by Anticancer Treatment.
    Intern Med. 2017;56:1357-1361.
    PubMed     Text format     Abstract available


    Isr Med Assoc J

  23. LEVY T
    The importance of HPV testing for cervical cancer screening in Israel.
    Isr Med Assoc J. 2017;19:644-465.
    PubMed     Text format    


    J Cytol

  24. AKINFOLARIN AC, Olusegun AK, Omoladun O, Omoniyi-Esan GO, et al
    Age and Pattern of Pap Smear Abnormalities: Implications for Cervical Cancer Control in a Developing Country.
    J Cytol. 2017;34:208-211.
    PubMed     Text format     Abstract available


    J Family Reprod Health

  25. SHRESTHA S, Dhakal P
    Knowledge, Attitude and Practice Regarding Cervical Cancer Screening Among Women Attending a Teaching Hospital, Bharatpur, Chitwan.
    J Family Reprod Health. 2017;11:18-23.
    PubMed     Text format     Abstract available


    Lancet HIV

  26. KELLY H, Weiss HA, Benavente Y, de Sanjose S, et al
    Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
    Lancet HIV. 2017 Oct 26. pii: S2352-3018(17)30149.
    PubMed     Text format     Abstract available

  27. DE VRIES HJC, Steenbergen RDM
    The effect of ART on cervical cancer precursor lesions.
    Lancet HIV. 2017 Oct 26. pii: S2352-3018(17)30189.
    PubMed     Text format    


    Magn Reson Imaging

  28. WANG P, Thapa D, Wu G, Sun Q, et al
    A study on diffusion and kurtosis features of cervical cancer based on non-Gaussian diffusion weighted model.
    Magn Reson Imaging. 2017 Nov 2. pii: S0730-725X(17)30241.
    PubMed     Text format     Abstract available


    Mol Med Rep

  29. CHEN G, Huang P, Xie J, Li R, et al
    microRNA211 suppresses the growth and metastasis of cervical cancer by directly targeting ZEB1.
    Mol Med Rep. 2017 Nov 7. doi: 10.3892/mmr.2017.8006.
    PubMed     Text format     Abstract available


    Obstet Gynecol

  30. CORTESSIS VK, Barrett M, Brown Wade N, Enebish T, et al
    Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002307.
    PubMed     Text format     Abstract available

  31. KAMPHUIS EI, Naber SK, Danhof NA, Habbema JDF, et al
    Effect of Cervical Cancer Screening Programs on Preterm Birth: A Decision and Cost-Effectiveness Analysis.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002366.
    PubMed     Text format     Abstract available


    Oncol Lett

  32. SHI WJ, Liu H, Wu D, Tang ZH, et al
    E6/E7 proteins are potential markers for the screening and diagnosis of cervical pre-cancerous lesions and cervical cancer in a Chinese population.
    Oncol Lett. 2017;14:6251-6258.
    PubMed     Text format     Abstract available


    Oncotarget

  33. CHI S, Shen L, Hua T, Liu S, et al
    Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.
    Oncotarget. 2017;8:79061-79072.
    PubMed     Text format     Abstract available

  34. LIU GF, Zhang SH, Li XF, Cao LY, et al
    Overexpression of microRNA-132 enhances the radiosensitivity of cervical cancer cells by down-regulating Bmi-1.
    Oncotarget. 2017;8:80757-80769.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  35. ASSAD DX, Borges GA, Avelino SR, Guerra ENS, et al
    Additive cytotoxic effects of radiation and mTOR inhibitors in a cervical cancer cell line.
    Pathol Res Pract. 2017 Nov 2. pii: S0344-0338(17)30883.
    PubMed     Text format     Abstract available


    Rheum Dis Clin North Am

  36. HEINLEN L, Chakravarty EF
    Reproductive Health Screening in Women with Autoimmune Diseases.
    Rheum Dis Clin North Am. 2017;43:161-171.
    PubMed     Text format     Abstract available


    Surg Oncol

  37. KIM HS, Kim R, Lee M
    Super-radical hysterectomy for recurrent cervical cancer.
    Surg Oncol. 2017;26:331-332.
    PubMed     Text format     Abstract available


    Ultrasound Obstet Gynecol

  38. TESTA AC, Moro F, Pasciuto T, Moruzzi MC, et al
    Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultras
    Ultrasound Obstet Gynecol. 2017 Nov 8. doi: 10.1002/uog.18953.
    PubMed     Text format     Abstract available


    Womens Health Issues

  39. MOSS JL, Liu B, Feuer EJ
    Urban/Rural Differences in Breast and Cervical Cancer Incidence: The Mediating Roles of Socioeconomic Status and Provider Density.
    Womens Health Issues. 2017 Nov 3. pii: S1049-3867(17)30093.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: